BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 35839681)

  • 1. Facile synthesis of [ONON] type titanium
    Zhao T; Wang P; Liu N; Li S; Yang M; Yang Z
    J Inorg Biochem; 2022 Oct; 235():111925. PubMed ID: 35839681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, in vitro antitumor evaluation and structure activity relationship of heptacoordinated amino-bis(Phenolato) Ti(IV) complexes stabilized by 2,6-dipicolinic acid.
    Li S; Zhang X; Zhao T; Liu N; Zhang Y; Wang P; Yang Z; Huhn T
    J Biol Inorg Chem; 2024 Apr; 29(3):315-330. PubMed ID: 38722397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-tumoral Titanium
    Zhao T; Wang P; Zhang X; Liu N; Zhao W; Zhang Y; Yuan P; Li S; Yang M; Yang Z; Huhn T
    Curr Top Med Chem; 2023; 23(19):1835-1849. PubMed ID: 37151173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different ortho and para electronic effects on hydrolysis and cytotoxicity of diamino bis(phenolato) "salan" Ti(IV) complexes.
    Peri D; Meker S; Manna CM; Tshuva EY
    Inorg Chem; 2011 Feb; 50(3):1030-8. PubMed ID: 21214265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and X-ray structure analysis of cytotoxic heptacoordinated Salan hafnium
    Zhao T; Wang P; Liu N; Zhao W; Yang M; Li S; Yang Z; Sun B; Huhn T
    J Inorg Biochem; 2023 Mar; 240():112094. PubMed ID: 36525714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific Design of Titanium(IV) Phenolato Chelates Yields Stable and Accessible, Effective and Selective Anticancer Agents.
    Meker S; Braitbard O; Hall MD; Hochman J; Tshuva EY
    Chemistry; 2016 Jul; 22(29):9986-95. PubMed ID: 27320784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, characterization, cytotoxicity, and hydrolytic behavior of C2- and C1-symmetrical Ti(IV) complexes of tetradentate diamine bis(phenolato) ligands: a new class of antitumor agents.
    Peri D; Meker S; Shavit M; Tshuva EY
    Chemistry; 2009; 15(10):2403-15. PubMed ID: 19156656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytotoxic salan-titanium(IV) complexes: high activity toward a range of sensitive and drug-resistant cell lines, and mechanistic insights.
    Manna CM; Braitbard O; Weiss E; Hochman J; Tshuva EY
    ChemMedChem; 2012 Apr; 7(4):703-8. PubMed ID: 22262543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Highly Stable Tetra-Phenolato Titanium(IV) Agent Formulated into Nanoparticles Demonstrates Anti-Tumoral Activity and Selectivity.
    Meker S; Braitbard O; Margulis-Goshen K; Magdassi S; Hochman J; Tshuva EY
    Molecules; 2015 Oct; 20(10):18526-38. PubMed ID: 26473816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Probing the Mechanism of Action of Bis(phenolato) Amine (ONO Donor Set) Titanium(IV) Anticancer Agents.
    Musa M; Abid M; Bradshaw TD; Boocock DJ; Coveney C; Argent SP; Woodward S
    J Med Chem; 2024 Feb; 67(4):2732-2744. PubMed ID: 38331433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Major impact of N-methylation on cytotoxicity and hydrolysis of salan Ti(IV) complexes: sterics and electronics are intertwined.
    Meker S; Manna CM; Peri D; Tshuva EY
    Dalton Trans; 2011 Oct; 40(38):9802-9. PubMed ID: 21874187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydrolytically Stable and Cytotoxic [ONO
    Pedko A; Rubanovich E; Tshuva EY; Shurki A
    Inorg Chem; 2022 Nov; 61(44):17653-17661. PubMed ID: 36273341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential cytotoxicity induced by the Titanium(IV)Salan complex Tc52 in G2-phase independent of DNA damage.
    Pesch T; Schuhwerk H; Wyrsch P; Immel T; Dirks W; Bürkle A; Huhn T; Beneke S
    BMC Cancer; 2016 Jul; 16():469. PubMed ID: 27412346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mononuclear titanium(IV)-citrate complexes from aqueous solutions: pH-specific synthesis and structural and spectroscopic studies in relevance to aqueous titanium(IV)-citrate speciation.
    Kefalas ET; Panagiotidis P; Raptopoulou CP; Terzis A; Mavromoustakos T; Salifoglou A
    Inorg Chem; 2005 Apr; 44(8):2596-605. PubMed ID: 15819544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytotoxic titanium salan complexes: surprising interaction of salan and alkoxy ligands.
    Immel TA; Groth U; Huhn T
    Chemistry; 2010 Mar; 16(9):2775-89. PubMed ID: 20104550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unexpected influence of stereochemistry on the cytotoxicity of highly efficient Ti(IV) salan complexes: new mechanistic insights.
    Manna CM; Armony G; Tshuva EY
    Chemistry; 2011 Dec; 17(50):14094-103. PubMed ID: 22076809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and X-ray structure analysis of cytotoxic heptacoordinate sulfonamide salan titanium(IV)-bis-chelates.
    Zhao T; Grützke M; Götz KH; Druzhenko T; Huhn T
    Dalton Trans; 2015 Oct; 44(37):16475-85. PubMed ID: 26325575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenolato Ti(IV) hexacoordinate complexes for anticancer chemotherapy: enhancement of solubility, hydrolytic stability, and cytotoxicity.
    Taha M; Tshuva EY
    Dalton Trans; 2023 Jun; 52(22):7664-7672. PubMed ID: 37199994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytotoxic homoleptic Ti(iv) compounds of ONO-type ligands: synthesis, structures and anti-cancer activity.
    Manne R; Miller M; Duthie A; Guedes da Silva MFC; Tshuva EY; Basu Baul TS
    Dalton Trans; 2018 Dec; 48(1):304-314. PubMed ID: 30516219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High antitumor activity of highly resistant salan-titanium(IV) complexes in nanoparticles: an identified active species.
    Meker S; Margulis-Goshen K; Weiss E; Magdassi S; Tshuva EY
    Angew Chem Int Ed Engl; 2012 Oct; 51(42):10515-7. PubMed ID: 22961758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.